Latham

Latham BioPharm Group (LBG) is a leading life sciences consultancy that provides strategic, technical, and operational support to biotechnology and pharmaceutical companies, as well as government agencies. The firm specializes in product development, regulatory affairs, and non-dilutive funding, particularly through government contracts with agencies like BARDA and the Department of Defense. LBG offers expertise across various therapeutic areas, including infectious diseases, oncology, and advanced therapies such as cell and gene therapy. In 2022, the company was acquired by Veranex, integrating its strategic consulting capabilities into a broader medtech and life sciences service platform. LBG is widely recognized for its ability to bridge the gap between innovative science and commercial or government-funded success.